Skip to content
ATDbbeta
Bristol Myers Squibb and Gilead Sciences are putting their media accounts into review

Bristol Myers Squibb and Gilead Sciences are putting their media accounts into review

Articleadage.com

Two major biopharmaceutical media accounts currently handled by Omnicom—Bristol Myers Squibb and Gilead Sciences—are in review or set to go into review.

Last updated Apr 2, 2026 by ATDb automated enrichment · Connections updated May 3, 2026

Source
Ad Age
Published
Apr 2, 2026
Topic
Omnicom
Mentions
1

Loading relationships...